InsiderTrades.com logo
$2 Trillion Disappears Because of Fed's Secretive New Move
From Stansberry Research   |   Ad
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Click here to see his new research now.

YMAB Insider Trading

Insider Ownership Percentage: 22.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,570,307.80

Y-mAbs Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Y-mAbs Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Y-mAbs Therapeutics Share Price & Price History

Current Price: $8.28
Price Change: ▼ Price Decrease of -0.29 (-3.38%)
As of 12/20/2024 06:17 PM ET

This chart shows the closing price history over time for YMAB up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
From Brownstone Research   |   Ad
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Click here to watch this demo and decide for yourself.

Y-mAbs Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2024Thomas GadInsiderSell30,000$12.97$389,100.0067,681View SEC Filing Icon  
9/13/2024Thomas GadInsiderSell65,000$13.47$875,550.0097,681View SEC Filing Icon  
8/26/2024Joris WilmsCOOSell5,000$14.69$73,450.0030,600View SEC Filing Icon  
6/10/2024Gerard BerDirectorSell722$12.00$8,664.001,608View SEC Filing Icon  
6/10/2024Thomas GadInsiderSell35,000$12.03$421,050.00197,681View SEC Filing Icon  
5/31/2024Bo KruseCFOSell31,371$12.07$378,647.97210,877View SEC Filing Icon  
5/23/2024Thomas GadInsiderSell7,351$13.00$95,563.00232,681View SEC Filing Icon  
5/21/2024Thomas GadInsiderSell25,000$12.00$300,000.00240,032View SEC Filing Icon  
3/5/2024Vignesh RajahSVPSell1,711$16.53$28,282.8333,889View SEC Filing Icon  
12/15/2023Thomas GadInsiderSell50,000$6.61$330,500.00265,032View SEC Filing Icon  
12/13/2023Thomas GadInsiderSell50,000$6.58$329,000.00365,032View SEC Filing Icon  
12/11/2023Biotech Aps WgDirectorBuy102,863$7.01$721,069.634,552,778View SEC Filing Icon  
12/7/2023Biotech Aps WgDirectorBuy6,183$6.50$40,189.504,431,412View SEC Filing Icon  
11/29/2023Biotech Aps WgDirectorBuy51,837$5.97$309,466.894,425,229View SEC Filing Icon  
11/27/2023Johan Wedell-WedellsborgDirectorBuy62,516$5.49$343,212.844,342,721View SEC Filing Icon  
11/20/2023Thomas GadInsiderSell75,000$5.30$397,500.00490,032View SEC Filing Icon  
5/15/2023Johan Wedell-WedellsborgDirectorBuy101,740$9.65$981,791.004,280,205View SEC Filing Icon  
11/15/2022Vignesh RajahCMOBuy1,195$4.92$5,879.404,266View SEC Filing Icon  
2/22/2022Bo KruseCFOSell4,000$7.85$31,400.00View SEC Filing Icon  
2/9/2022Thomas GadInsiderSell64,276$6.96$447,360.96View SEC Filing Icon  
2/7/2022Thomas GadInsiderSell91,031$7.59$690,925.29View SEC Filing Icon  
2/4/2022Bo KruseCFOSell4,000$7.97$31,880.00View SEC Filing Icon  
2/3/2022Thomas GadInsiderSell35,060$7.90$276,974.00View SEC Filing Icon  
2/1/2022Thomas GadInsiderSell8,000$10.15$81,200.00View SEC Filing Icon  
1/24/2022Bo KruseCFOSell4,000$9.84$39,360.00View SEC Filing Icon  
1/24/2022Thomas GadInsiderSell88,055$10.63$936,024.65View SEC Filing Icon  
1/20/2022Thomas GadInsiderSell112,767$11.33$1,277,650.11View SEC Filing Icon  
1/18/2022Thomas GadInsiderSell8,000$11.54$92,320.00View SEC Filing Icon  
1/4/2022Bo KruseCFOSell4,000$17.12$68,480.00View SEC Filing Icon  
12/22/2021Bo KruseCFOSell4,000$16.36$65,440.00View SEC Filing Icon  
See Full Table
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
From Behind the Markets   |   Ad
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Y-mAbs Therapeutics (NASDAQ:YMAB)

70.85% of Y-mAbs Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at YMAB by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Y-mAbs Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/19/2024Principal Financial Group Inc.20,294$0.27M0.0%N/A0.045%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC69,222$0.91M0.0%+433.4%0.155%Search for SEC Filing on Google Icon
11/18/2024Empire Financial Management Company LLC16,000$0.21M0.1%N/A0.036%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC813,489$10.70M0.0%+6.2%1.816%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC69,222$0.91M0.0%+433.4%0.155%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd11,300$0.15M0.0%-54.1%0.025%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP136,714$1.80M0.0%-14.8%0.305%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,209,781$15.91M0.0%+50.4%2.701%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.95,383$1.25M0.0%-73.4%0.213%Search for SEC Filing on Google Icon
11/14/2024Caligan Partners LP1,195,253$15.72M5.0%+105.3%2.669%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC44,591$0.59M0.0%-23.5%0.100%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank3,324$44K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/13/2024FMR LLC36,416$0.48M0.0%+23.1%0.081%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.279,577$3.68M0.0%+9.4%0.627%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC10,149$0.13M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.94,225$1.24M0.0%-46.5%0.211%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.20,294$0.27M0.0%N/A0.046%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC108,684$1.43M0.1%+21.1%0.244%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.8,572$0.11M0.0%+66.3%0.020%Search for SEC Filing on Google Icon
10/10/2024Exchange Traded Concepts LLC12,872$0.17M0.0%-11.2%0.029%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC13,566$0.18M0.0%N/A0.031%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC6,597$80K0.0%-91.5%0.015%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.358,945$4.34M0.0%-76.5%0.818%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC349,784$4.23M0.0%+23.8%0.797%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC21,926$0.27M0.0%-42.1%0.050%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC126,389$1.53M0.0%+143.4%0.288%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC6,597$80K0.0%-91.5%0.015%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd24,621$0.30M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC64,637$0.78M0.0%-43.9%0.147%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP484,431$5.85M0.0%+15.7%1.104%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA82,202$0.99M0.0%+3.5%0.187%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC89,735$1.08M0.1%+4.2%0.204%Search for SEC Filing on Google Icon
8/6/2024Acadian Asset Management LLC323,175$3.90M0.0%-46.3%0.736%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp120,954$1.46M0.0%+8.0%0.276%Search for SEC Filing on Google Icon
5/28/2024Boston Partners34,165$0.56M0.0%N/A0.078%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System3,700$60K0.0%-38.9%0.008%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.154,016$2.50M0.0%-39.1%0.351%Search for SEC Filing on Google Icon
5/16/2024Caxton Associates LP18,807$0.31M0.0%N/A0.043%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD21,158$0.35M0.0%+8.5%0.048%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.3,701$60K0.0%+39.9%0.008%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC602,314$9.79M0.0%-24.9%1.373%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,069,517$33.65M0.0%-7.8%4.717%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC11,963$0.20M0.0%-44.5%0.027%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.13,729$0.22M0.0%-7.4%0.031%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.8,390$0.14M0.0%+66.1%0.019%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC127,551$2.07M0.0%-64.2%0.291%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC6,686$46K0.0%+345.4%0.015%Search for SEC Filing on Google Icon
2/13/2024Campbell & CO Investment Adviser LLC82,391$0.56M0.1%N/A0.189%Search for SEC Filing on Google Icon
2/9/2024Trexquant Investment LP28,616$0.20M0.0%-62.6%0.066%Search for SEC Filing on Google Icon
2/8/2024Massachusetts Financial Services Co. MA79,617$0.54M0.0%-3.1%0.183%Search for SEC Filing on Google Icon
2/6/2024Sapient Capital LLC43,700$0.30M0.0%N/A0.100%Search for SEC Filing on Google Icon
2/6/2024Los Angeles Capital Management LLC356,530$2.43M0.0%+17.3%0.817%Search for SEC Filing on Google Icon
2/6/2024New York Life Investment Management LLC68,932$0.47M0.0%-2.9%0.158%Search for SEC Filing on Google Icon
2/5/2024Russell Investments Group Ltd.16,928$0.12M0.0%-36.5%0.039%Search for SEC Filing on Google Icon
2/2/2024Bailard Inc.16,900$0.12M0.0%N/A0.039%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.44,474$0.30M0.0%+4,708.0%0.102%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio78,700$0.54M0.0%-11.6%0.180%Search for SEC Filing on Google Icon
1/29/2024Sapient Capital LLC43,700$0.30M0.0%N/A0.100%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.26,090$0.18M0.0%+4.4%0.060%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.5,050$34K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/19/2024Denali Advisors LLC16,400$0.11M0.0%-80.9%0.038%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC21,559$0.15M0.0%+17.5%0.049%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC28,095$0.19M0.0%+34.0%0.064%Search for SEC Filing on Google Icon
12/19/2023Public Employees Retirement System of Ohio16,100$88K0.0%-11.0%0.037%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP137,299$0.75M0.1%+208.3%0.315%Search for SEC Filing on Google Icon
11/14/2023Trexquant Investment LP76,585$0.42M0.0%+417.5%0.176%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC26,670$0.15M0.0%-40.0%0.061%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC811,261$4.42M0.0%+24.0%1.860%Search for SEC Filing on Google Icon
11/8/2023Massachusetts Financial Services Co. MA82,131$0.45M0.0%+258.2%0.188%Search for SEC Filing on Google Icon
11/8/2023New York Life Investment Management LLC70,955$0.39M0.0%-13.7%0.163%Search for SEC Filing on Google Icon
11/7/2023Jump Financial LLC18,800$0.10M0.0%-52.6%0.043%Search for SEC Filing on Google Icon
11/6/2023Los Angeles Capital Management LLC303,920$1.66M0.0%+12.2%0.697%Search for SEC Filing on Google Icon
11/6/2023Victory Capital Management Inc.109,500$0.60M0.0%+20.1%0.251%Search for SEC Filing on Google Icon
10/26/2023Strs Ohio89,000$0.49M0.0%+20.1%0.204%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC20,971$0.11M0.0%+29.4%0.048%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC18,349$100K0.0%N/A0.042%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC7,317$49K0.0%-84.6%0.017%Search for SEC Filing on Google Icon
8/14/2023UniSuper Management Pty Ltd325,000$2.21M0.0%N/A0.745%Search for SEC Filing on Google Icon
8/14/2023Polar Capital Holdings Plc2,103,298$14.28M0.1%+5.6%4.822%Search for SEC Filing on Google Icon
8/14/2023Graham Capital Management L.P.10,075$68K0.0%N/A0.023%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.13,722$93K0.0%+25.3%0.031%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC654,088$4.44M0.0%+63.7%1.497%Search for SEC Filing on Google Icon
8/7/2023New York Life Investment Management LLC82,262$0.56M0.0%-43.6%0.188%Search for SEC Filing on Google Icon
8/3/2023Los Angeles Capital Management LLC270,926$1.84M0.0%N/A0.620%Search for SEC Filing on Google Icon
8/2/2023Avestar Capital LLC10,000$68K0.0%N/A0.023%Search for SEC Filing on Google Icon
7/31/2023Strs Ohio74,100$0.50M0.0%-50.2%0.170%Search for SEC Filing on Google Icon
7/27/2023Victory Capital Management Inc.91,180$0.62M0.0%N/A0.209%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC6,484$44K0.0%-55.4%0.015%Search for SEC Filing on Google Icon
7/24/2023Rice Hall James & Associates LLC93,022$0.63M0.0%+4.0%0.213%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC16,208$0.11M0.0%N/A0.037%Search for SEC Filing on Google Icon
7/18/2023Denali Advisors LLC85,900$0.58M0.2%+934.9%0.197%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC6,484$44K0.0%-55.4%0.015%Search for SEC Filing on Google Icon
5/15/2023AIGH Capital Management LLC428,412$2.15M0.8%N/A0.981%Search for SEC Filing on Google Icon
5/15/2023XTX Topco Ltd163,277$0.82M0.2%+323.3%0.374%Search for SEC Filing on Google Icon
5/12/2023Rice Hall James & Associates LLC89,480$0.45M0.0%+2.7%0.205%Search for SEC Filing on Google Icon
5/11/2023Acadian Asset Management LLC399,582$2M0.0%+101.2%0.915%Search for SEC Filing on Google Icon
5/10/2023Connor Clark & Lunn Investment Management Ltd.174,114$0.87M0.0%+1.9%0.399%Search for SEC Filing on Google Icon
5/8/2023New York Life Investment Management LLC145,808$0.73M0.0%N/A0.334%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.63,956$0.32M0.0%-49.9%0.146%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC40,900$0.21M0.0%N/A0.094%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Y-mAbs Therapeutics logo
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer in the United States and internationally. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment of pediatric patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow. The company is also developing DANYELZA for the treatment of patients with second-line relapsed osteosarcoma and is in Phase II clinical study; GD2-SADA, which is in Phase I clinical trial for the treatment of GD2 positive solid tumor; and Omburtamab, a murine monoclonal antibody for the treatment of central nervous system/leptomeningeal metastases from neuroblastoma, as well as SADA PRIT technology platform. In addition, it is engages in the developing of CD38-SADA and GD2-GD3 Vaccine. The company has a license agreement with Memorial Sloan Kettering Cancer Center and Massachusetts Institute of Technology to develop and commercialize licensed products. Y-mAbs Therapeutics, Inc. was incorporated in 2015 and is headquartered in New York, New York.
Read More on Y-mAbs Therapeutics

Today's Range

Now: $8.28
Low: $8.00
High: $8.50

50 Day Range

MA: $12.36
Low: $8.28
High: $15.69

52 Week Range

Now: $8.28
Low: $6.10
High: $20.90

Volume

1,143,018 shs

Average Volume

328,133 shs

Market Capitalization

$370.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top insider shareholders include:
  1. Biotech Aps Wg (Director)
  2. Johan Wedell-Wedellsborg (Director)
  3. Thomas Gad (Insider)
  4. Bo Kruse (CFO)
  5. Vignesh Rajah (SVP)
  6. Joris Wilms (COO)
  7. Gerard Ber (Director)
Learn More about top insider investors at Y-mAbs Therapeutics.

Who are the major institutional investors of Y-mAbs Therapeutics?

Y-mAbs Therapeutics' top institutional shareholders include:
  1. State Street Corp — 2.70%
  2. Caligan Partners LP — 2.67%
  3. Geode Capital Management LLC — 1.82%
  4. Charles Schwab Investment Management Inc. — 0.63%
  5. Wellington Management Group LLP — 0.31%
  6. Rice Hall James & Associates LLC — 0.24%
Learn More about top institutional investors of Y-mAbs Therapeutics stock.

Which major investors are selling Y-mAbs Therapeutics stock?

During the previous quarter, YMAB stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. Connor Clark & Lunn Investment Management Ltd.
  3. Wellington Management Group LLP
  4. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  5. XTX Topco Ltd
  6. Exchange Traded Concepts LLC
During the previous year, company insiders that have sold Y-mAbs Therapeutics company stock include:
  1. Biotech Aps Wg (Director)
  2. Johan Wedell-Wedellsborg (Director)
  3. Thomas Gad (Insider)
  4. Bo Kruse (CFO)
  5. Vignesh Rajah (SVP)
Learn More investors selling Y-mAbs Therapeutics stock.

Which major investors are buying Y-mAbs Therapeutics stock?

Within the last quarter, YMAB stock was purchased by institutional investors including:
  1. Caligan Partners LP
  2. State Street Corp
  3. Barclays PLC
  4. Barclays PLC
  5. Geode Capital Management LLC
  6. Charles Schwab Investment Management Inc.
  7. Principal Financial Group Inc.
  8. Principal Financial Group Inc.
During the last year, these company insiders have bought Y-mAbs Therapeutics stock:
  1. Biotech Aps Wg (Director)
  2. Johan Wedell-Wedellsborg (Director)
Learn More investors buying Y-mAbs Therapeutics stock.
$2 Trillion Disappears Because of Fed's Secretive New Move
From Stansberry Research   |   Ad
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Click here to see his new research now.